SC

Shivananda Chickavenkatarayappa

Active Director Director DIN 09529602
DIN 09529602 First appointment Mar 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Shivananda Chickavenkatarayappa

Data last updated:

Shivananda Chickavenkatarayappa is a Director at Re-Life Medical & Rehabilitation Services Private Limited (since 2022). The company operates in Healthcare.

DIN 09529602
Primary Designation Director
Industry Healthcare
First Appointment 08 Mar 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Mar 20222022Active

Board colleagues of Shivananda Chickavenkatarayappa

Directorship timeline

Open interactive timeline →
Re-Life Medical & Rehabilitation Services Private Limited
Premium access

Shareholding and investment profile for Shivananda Chickavenkatarayappa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivananda Chickavenkatarayappa

Shivananda Chickavenkatarayappa currently holds 1 directorship: Re-Life Medical & Rehabilitation Services Private Limited (Director, since 08 Mar 2022).

Shivananda Chickavenkatarayappa was first appointed on 08 Mar 2022 as Director at Re-Life Medical & Rehabilitation Services Private Limited.

The current boards of Shivananda Chickavenkatarayappa's companies include Shivananda Supriya (Re-Life Medical & Rehabilitation Services Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available